Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 1

Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.

2,861 public trials 319 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 1 trial results

Completed

Assess the Impact of Insulclock on Glycemic Variability and Treatment Compliance in Uncontrolled DM1 Patients

NCT04847778

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations
  • Endocrinology and Nutrition Unit, Arquitecto Marcide Hospital Ferrol, A Coruña, Spain
  • Endocrinology and Nutrition Service, Hospital de Cruces. Bilbao, Spain
  • Endocrinology and Nutrition Service, Hospital Central de Asturias Oviedo, Spain
  • Endocrinology and Nutrition Unit /Diabetes Unit, Hospital General de Segovia Segovia, Spain
View Trial Details
Completed

Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients

NCT02666430

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Mylan Investigator Site Fresno, California, United States
  • Mylan Investigator Site Greenbrae, California, United States
  • Mylan Investigator Site La Jolla, California, United States
  • Mylan Investigator Site Northridge, California, United States
View all 81 locations
View Trial Details
Completed

Mylan Insulin Glargine Study

NCT03376789

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations
  • Mylan Investigator Site Fresno, California, United States
  • Mylan Investigator Site Greenbrae, California, United States
  • Mylan Investigator Site Huntington Beach, California, United States
  • Mylan Investigator Site La Mesa, California, United States
View all 38 locations
View Trial Details
Completed

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)

NCT02227862

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Mylan Investigational Site Bell Gardens, California, United States
  • Mylan Investigational Site Fresno, California, United States
  • Mylan Investigational Site Greenbrae, California, United States
  • Mylan Investigational Site La Jolla, California, United States
View all 162 locations
View Trial Details

Related conditions